Cargando…
Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009
We have analyzed our experience regarding use of tyrosine kinase inhibitors especially imatinib mesylate in patients of chronic myeloid leukemia-chronic phase over last 7 years at our center (2002-2009). The object was to report long-term efficacy (hematological, cytogenetic and molecular) and toxic...
Autores principales: | Agarwal, M. B., Agarwal, Usha M., Rathi, Shonali S., Masurkar, Sangeeta, Zaveri, Bindi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902625/ https://www.ncbi.nlm.nih.gov/pubmed/24516310 http://dx.doi.org/10.4103/0971-5851.123741 |
Ejemplares similares
-
Report of chronic myeloid leukemia in chronic phase from Tata Memorial Hospital, Mumbai, 2002-2008
por: Parikh, Purvish
Publicado: (2013) -
Report of chronic myeloid leukemia in chronic phase from Dr. Senthil Rajappa, 2002-2009
por: Rajappa, Senthil, et al.
Publicado: (2013) -
Report of chronic myelogenous leukemia in chronic phase from, Asian Institute of Oncology, Mumbai, 2002-2010
por: Bansal, Shweta, et al.
Publicado: (2013) -
Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
por: Ganesan, Prasanth, et al.
Publicado: (2013) -
Report of chronic myeloid leukemia from Indira Gandhi Institute of Medical Sciences, Regional Cancer Center, 2002-2009
por: Prasad, Rajiv Ranjan, et al.
Publicado: (2013)